Catalyst Wire Dossier Catalyst Wire Dossier

vaniprevir (MK7009)

vaniprevir · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for vaniprevir (MK7009), covering 2015-10-22 to 2015-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN) [Phase 2]

See pricing